Abridge inks deals with Nvidia and Lilly – statnews.com

Home
What's the word?
Test your knowledge with our new weekday mini crossword
By Mario Aguilar
June 11, 2026
Health Tech Correspondent
Mario Aguilar
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.
NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as it aims to gain an edge in the competitive market for software that supports doctors and streamlines hospital billing and operations.
Abridge, which is used by hundreds of health systems, devoted much of a midtown Manhattan event to demonstrating new elements of its platform that documents patient visits and offers guidance and suggestions to clinicians before, during, and after a visit.
Advertisement
But the billboard announcements were partnerships. Draped head-to-toe in black, on a day forecast to be in the 90s, Abridge CEO Shiv Rao announced that Eli Lilly had made a strategic investment in the company, and that Abridge had a new collaboration with Nvidia to develop “the first foundation model purpose-built for clinical conversations.”
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
Monthly
$39
Totals $468 per year
Totals $468 per year
Starter
$30
for 3 months, then $399/year
Then $399/year
Annual
$399
Save 15%
Save 15%
11+ Users
Custom
Savings start at 25%!
Savings start at 25%!
2-10 Users
$300
Annually per user
$300 Annually per user
To read the rest of this story subscribe to STAT+.
Mario Aguilar
Health Tech Correspondent
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.
Your data will be processed in accordance with our Privacy Policy and Terms of Service. You may opt out of receiving STAT communications at any time.
By Allison DeAngelis, Elaine Chen, and Adam Feuerstein
By Chelsea Cirruzzo and Daniel Payne
Advertisement
By Isabella Cueto
By Mario Aguilar
By Lauren Chan

By Katie Palmer

By Elaine Chen

By Damian Garde

By Brittany Trang

By Andrew Joseph
Share options
X
Bluesky
LinkedIn
Facebook
Doximity
Copy link
Reprints
A decade of reporting from the frontiers of health and medicine
Company
Account
More

source